EdgarLookup
DEF 14A

DEF 14A

Company
BRAINSTORM CELL THERAPEUTICS INC.
Filed
May 11, 2016
Period of Report
June 21, 2016
Accession Number
0001144204-16-100632

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →